Recruiting A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) NCT02332668 Conditions Classical Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +18 more Locations Call for Information (Investigational Site 0019) — Aurora, Colorado, United States Call for Information (Investigational Site 0024) — Chicago, Illinois, United States Call for Information (Investigational Site 0026) — Boston, Massachusetts, United States Call for Information (Investigational Site 0031) — New York, United States View all 16 locations View more locations Show fewer locations Loading locations... View Trial Details